Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth

January 23, 2026 updated by: Children's Hospital of Philadelphia

Feasibility Testing of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth

This study continues an adaptation of care coordination to address the needs of women after preterm birth. This is a small single arm open trial designed to test intervention implementation and refine the intervention before ongoing feasibility testing.

Study Overview

Detailed Description

Interventionists will be trained in care coordination strategies and Motivational Interviewing (MI) techniques. Following training, investigators will enroll eligible women from a postpartum unit at a single hospital, or within two weeks of birth. Investigators will assess feasibility, adoption, reach, and fidelity of the intervention and of study data collections strategies. The intervention protocol will be revised to reflect these assessments.

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Hospital of the University of Pennsylvania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 45 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Female
  2. Less than 45 years old
  3. History of preterm birth (< 34 weeks gestational age or 34 - 36 weeks with identifiable risk factors for recurrent preterm birth which may include low preventive care utilization, tobacco use, obesity, depression or anxiety, or history of unmet contraceptive needs)
  4. Intention to seek pediatric care at one of two pediatric primary care sites
  5. Medicaid insurance

Exclusion Criteria:

  1. History of sterilization procedure.
  2. Plan to move away from the area or transfer pediatric primary care within six months of enrollment.
  3. Limited English proficiency

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Intervention Arm
This intervention will combine care coordination and motivational interviewing strategies.
Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Screening Rate (Feasibility)
Time Frame: Screening phase (Up to 1 week prior to enrollment)
The study team will compare the number of potentially eligible participants to those who are screened for eligibility. The number screened will be defined as the number of people whose are reviewed to approach for enrollment. The number of potentially eligible participants will be considered the number of women with preterm births with Medicaid insurance.
Screening phase (Up to 1 week prior to enrollment)
Enrollment Rate (Feasibility)
Time Frame: Screening phase (Up to one week prior to enrollment)
The study team will track the proportion of eligible women approached for enrollment who enroll in the study.
Screening phase (Up to one week prior to enrollment)
Reasons for Non-participation (Acceptability)
Time Frame: Screening phase (Up to 1 week prior to enrollment)
For women who decline enrollment we will ask them, if they are willing, to provide reasons for non-participation and potential study modifications that might have encouraged them to participate. Responses will be tabulated and reviewed for potential themes.
Screening phase (Up to 1 week prior to enrollment)
Retention Rate (Feasibility)
Time Frame: Enrollment through six months
The study team will track the proportion of enrolled participants who complete the intervention and the study assessments.
Enrollment through six months
Number of Completed Assessments (Feasibility)
Time Frame: Enrollment through six months
The study team will track the proportion of the baseline, 3-month, and 6-month assessments that are completed.
Enrollment through six months
Care Coordination Fidelity (Feasibility)
Time Frame: Enrollment through six months
We will assess the proportion of intervention components completed, including interventionist completion of screening tools, as well as other tasks outlined in the care plan, including focused education, navigation, and addressing barriers to care, screening.
Enrollment through six months
Motivational Interviewing (MI) Fidelity (Feasibility)
Time Frame: Enrollment through six months
OnePass is a validated tool used to evaluate MI practice and assess fidelity based on review of a single session, using 23 items to assess MI components.61 This tool yields a global score while also identifying specific areas for additional practice and training. Scores range from 1 - 7 with 5 considered a minimum for competence. Interventionists will complete at least one OnePass within a month of starting MI sessions with participants.
Enrollment through six months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Autonomy Support
Time Frame: Baseline and 3 months
Autonomy support will be measured with the short form of the Health Care Climate Questionnaire (6 items, range 6 - 42, Cronbach alpha 0.82). Scores on the short form 6-item version are calculated by averaging the individual item scores. Higher average scores represent a higher level of perceived autonomy support.
Baseline and 3 months
Change in Autonomous Motivation
Time Frame: Baseline and 6 months
Autonomous motivation will be measured using the Autonomous Motivation and External Regulation scales of the Treatment Self-Regulation Questionnaire (10 items, range 7 - 70, Cronbach alpha 0.90) with a higher score indicating higher emotion regulation strategy.
Baseline and 6 months
Count of Preventive Care Visits
Time Frame: 6 months
This will include postpartum visits, visits for contraceptive management, routine preventive care visits, and visits to follow-up on complications of pregnancy (secondary prevention). Visits will be abstracted from the health record and from interventionist records.
6 months
Proportion of Recommended Care Completed
Time Frame: 6 months
This Outcome Measure reports the average percentage of the recommended care plan completed among participants. Recommended care will be abstracted from a care plan completed within the first two weeks after enrollment. Completed care will be abstracted from the health record and from interventionist records.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 3, 2022

Primary Completion (Actual)

September 23, 2023

Study Completion (Actual)

September 23, 2023

Study Registration Dates

First Submitted

September 13, 2021

First Submitted That Met QC Criteria

November 12, 2021

First Posted (Actual)

November 15, 2021

Study Record Updates

Last Update Posted (Actual)

January 27, 2026

Last Update Submitted That Met QC Criteria

January 23, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data will be used to refine the protocol for further testing. There are no plans to share individual participant data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Care coordination and motivational interviewing

Subscribe